p53 tumor suppressor gene controls cell response to a variety of stresses inducing growth arrest or apoptosis in damaged cells. It largely determines the sensitivity of tumor and normal cells to radiation and chemotherapy, and, therefore, de®nes both the ecacy and limitations of anti-cancer treatment. To determine molecular mechanisms of p53-dependent stress response in normal tissues we identi®ed and compared the spectra of radiation-responsive genes in cells of dierent origin and p53 status using a cDNA array hybridization technique. The majority of genes identi®ed were p53-dependent and cell type speci®c. Several of the new p53 responders encode known secreted growth inhibitory factors. This suggests that p53, in addition to its intrinsic antiproliferation activity, can cause`bystander eect' by inducing export of growth suppressive stimuli from damaged cells to neighboring cells. Consistently, a p53-dependent accumulation of factors, which causes growth inhibitory eects in a variety of cell lines, was found after gamma irradiation in the media from established and primary cell cultures and in the urine of irradiated mice. Moreover, p53-dependent factors released by normal human ®broblasts potentiated the cytotoxic eect of a chemotherapeutic drug on co-cultivated tumor cells. This suggests a previously unknown role for normal cells in chemo-and radiation therapy of cancer.
Introduction
The p53 tumor suppressor gene encodes a nuclear transcription factor that accumulates in the cells in response to a variety of stresses; p53 activation can induce growth arrest or apoptosis in damaged cell. P53 is inactivated in the majority of human tumors; p53 inactivation is associated with the loss of the cell cycle checkpoint control, resistance to anti-cancer treatment and genomic instability leading to rapid tumor progression (reviewed in Gottlieb and Oren, 1996) . In normal development, p53 controls elimination of genetically damaged cells during early stages of embryogenesis (Norimura et al., 1996; Komarova et al., 1997) .
The biological eects of p53 are cell type speci®c. For example, in vivo it determines massive apoptosis in response to gamma irradiation or treatment with chemotherapeutic drugs only in early embryos and several sensitive tissues, including spleen and thymus (Lowe et al., 1993a; MacCallum et al., 1996; Komarova et al., 1997) . Many p53-mediated eects are achieved through the activity of p53-responsive genes. In fact, p53-dependent upregulation of p21/waf1 and 14-3-3s accounts in part for p53-mediated G1 and G2/M checkpoint controls, respectively (El-Deiry et al., 1993; Hermeking et al., 1997) , transcriptional activation of bax and the genes determining reactive oxygen metabolism promote apoptosis (Miyashita and Reed, 1995; Polyak et al., 1997) , while activation of mdm2 is involved in p53 feedback regulation (Wu et al., 1993) . To approach the molecular mechanisms underlying tissue speci®city of p53-mediated response, we compared the spectra of p53-responsive genes activated in dierent cell types of mouse and human origin by using hybridization with the cDNA arrays. We found that p53-dependent alterations in gene expression are tissue speci®c and identi®ed a number of new p53-responsive genes with a variety of patterns of regulation. By analysing the p53-responsive genes we suggested that p53 can control cellular export of growth inhibitory factors in response to stress and demonstrated this eect in vitro and in vivo. We also showed that p53-dependent secretion of growth inhibitors by normal cells could potentiate the eect of chemotherapeutic treatment indicating a new tumor suppressor function of p53.
Results

Identi®cation of new p53-responsive genes
We determined the spectra of the genes that alter their expression in response to gamma irradiation in a series of cell systems diering in their origin and p53 status. Speci®cally, we used p53-negative human ®broblasts MDAH041and their derivative, TR9-7, which expresses tetracycline-regulated wild type p53 cDNA (Agarwal et al., 1995) . The basal level of p53 expression in TR9-7 cells in the presence of tetracycline is similar to that of normal human diploid ®broblasts; p53 accumulates in these cells by either gamma irradiation or tetracycline deprivation. In addition to human ®broblasts, we used mRNA from spleen, thymus, and liver of wild type or p53-knockout mice (Jacks et al., 1994) , either untreated or taken 4 h after 10 Gy of gamma irradiation. Cells in the thymus and spleen undergo p53-dependent apoptosis, while neither liver cells nor ®brobasts display any evident fast response to DNA damage (Lowe et al., 1993a; MacCallum et al., 1996; Komarova et al., 1997) . 32 P-labeled complex cDNA probes were synthesized from each cellular mRNA population and hybridized to CLONTECH's Atlas (see CLONTECH website: www.clontech.com) cDNA arrays (human or mouse, depending on the mRNA origin) which contained 588 cDNAs each. Additionally,¯uorescently labeled cDNA probes from human ®broblasts were hybridized to two microarrays, which contained approximately 20 000 known and unknown human cDNAs (Schena et al., 1995) . CDNAs were chosen based on dierential expression by array hybridization and con®rmed by Northern blot-hybridization and semi-quantitative RT ± PCR. From this set of dierentially expressed cDNAs, we identi®ed the corresponding mRNA species, whose expression was aected by gamma irradiation, and distinguished between p53-dependent and p53-independent genes. Tables 1 and 2 contain the complete list of p53-responsive genes found by using CLONTECH Atlas and the genes of known origin found by hybridization with 20 000-cDNA-microarray.
The genes identi®ed include a number of known p53 responders (Tables 1 and 2) : p21/waf1, cyclin G, bax and several genes encoding enzymes of glutathione metabolism, con®rming the recent discovery of p53 involvement in the regulation of reactive oxygen species (Hermeking et al., 1997) . Interestingly, most of the arrayed cDNA that change expression after whole-body gamma irradiation of mice were found to be p53 dependent. For example, among 26 radiationresponsive genes of the spleen, 18 were p53 dependent, con®rming a unique role of p53 in radiation response. Dierent cell types varied dramatically in their content of p53-responsive genes. Only eight of 18 p53-responsive genes in the spleen were found to respond to p53 in other cell types analysed. Remarkably, the sets of p53-dependent genes expressed in thymus and spleen, both of which are highly sensitive to p53-dependent apoptosis, showed almost no similarity (Table 1) . Among the known p53 responders there was only one, cyclin G (Okamoto and Beach, 1994) , that was recognized as a p53-regulated gene in all mouse tissues analysed. p53-dependent upregulation of p21/waf1 and bax was evident in some of the cell types tested but was undetectable in others, possibly due to the low basal expression levels. The tissue speci®city of p53 responsiveness of some of the identi®ed genes seems to simply re¯ect the dierences in the basal levels of their expression among tissues. For example, p53-induced upregulation of p19/ink4/arf was evident in the spleen, where its basal level is low, and could not be detected in the thymus where its expression was high, p19/ink4/arf expression in the liver was below the sensitivity of hybridization. However, several genes (EGF, CSF-1, zyxin, GST-m1) with similar basal levels of expression in dierent tissues showed tissue speci®c response to p53, suggesting that p53 pathway can be modulated by unknown tissue speci®c factors.
The identi®ed genes can be classi®ed into several groups according to the mode of their response to p53. By comparing gamma-irradiated wild type p53 and p53-de®cient human ®broblasts, several genes were found to be strongly repressed in the p53-wild type cells (nos. 18 ± 25 in Table 2 and Figure 1b) . Since in our experiments mRNA was isolated shortly after the p53 activation, we could reliably detect only those negatively regulated genes that were repressed prior to the p53 activation. In fact, mRNA expression of such genes as stromelysin-1 (Figure 1b) , thrombomodulin or prostaglandin G/H synthase was deeply repressed in TR9-7 cells under normal conditions of growth ( Table  2) .
The largest group of p53 responders includes genes that are upregulated after gamma irradiation on p53 NF** *Position of putative p53 DNA-binding sites (distance from transcription start). ** Only coding sequence available. Abbreviations: : and ;, p53-dependent induction and suppression; (:) and (;), p53-independent induction and suppression; L, M, H ± low, medium and high hybridization signal; NI, noninducible; UD, undetectable; NF, not found; nd, not done. If no genomic sequences were available, closest homologs from other mammalian species were used; (R), rat sequence; (H), human sequence p53-dependent secretion of growth inhibitors EA Komarova et al wild type but not on p53-null background (p21/waf1, cyclin G, TGF-b2, etc). Another large group involves genes which basal expression levels was higher in p53-null cells than in p53 wild type cells. They were upregulated in p53 wild type cells and, in some cases, in p53-null cells after gamma irradiation (neuroleukin, ID-1, ID-3, see Figure 1b ). Another group of genes are subjects of complex regulation ( Figure 1a ). For example, cyclin B1 that is downregulated after gamma irradiation through the known mechanism involving mRNA degradation (Maity et al., 1995) was upregulated by p53 induced in TR9-7 cells by tetracyclin deprivation (Figure 1b ). The combined eects of the p53-dependent and p53-independent mechanisms of cyclin B1 explains why the radiation dependent decrease in cyclin B1 mRNA was more pronounced in the p53-null than in the p53-wild type background ( Figure 1b ).
p53-dependent cellular secretion of growth inhibitors in vitro
Newly identi®ed p53 responders can be organized into several groups according to their functional activities.
Genes that responded to p53 activation include transcription regulators (nos. 18 ± 20 in Table 1 and nos. 6 and 7 in Table 2 ), growth factors and their receptors (nos. 13 ± 17 in Table 1 ), and extracellular matrix proteins (nos. 9 ± 13 in Table 2 ). Another group of genes that were upregulated in a p53-dependent manner after gamma irradiation encode secreted proteins with a known growth inhibitory function. This group includes TGF-b2, inhibin-b (in ®broblasts), and a variety of serine protease inhibitors (spleen, liver and ®brobasts (nos. 10 ± 12 in Table 1 , nos. 15 ± 17 in Table 2 ). Insulin-like growth factor-binding protein 3 (IGBP3) de®ned earlier as a p53 responder (Buckbinder et al., 1995) also belongs to this group, although its p53-dependent upregulation was visible only in human ®broblasts. cDNA array hybridization does not distinguish between genes that are direct and indirect targets of p53. Analysis of DNA sequences within a +2000 bp range around the transcription start site revealed p53-binding motifs (El-Deiry et al., 1992) in some, but not all, of the identi®ed p53 responders (see Tables 1 and 2 ). These putative p53-binding sites provide tools for direct future experimental testing of the mechanisms that controls p53 responsiveness in the newly identi®ed genes. The presence of a number of secreted growth inhibitors among p53-responsive genes suggests that p53-dependent growth control may not only be limited to suppression of proliferation of damaged cell by intrinsic mechanisms, but may also involve induction and release of growth inhibitory factors aecting the surrounding cells (bystander eect). To test this hypothesis, we compared the eect of conditioned media collected from cells diering in their p53 status before and after p53 activation on the growth of target cells. As a source of conditioned media, we used several experimental cell systems, all representing isogenic cell lines diering in p53 status or activity. Speci®cally, (i) p53-null human ®broblasts MDAH041 were compared with their derivatives TR9-7, expressing tetracycline-regulated p53 (Agarwal et al., 1995) ; (ii) ConA cells (Komarova et al., 1997) , were compared with their variant in which p53 function was suppressed by transduction of a strong anti-p53 genetic suppressor element GSE-56 (Ossovskaya et al., 1996) ; (iii) wild type mouse embryo ®broblasts (MEF) transformed with an E1a and Ha-ras, line C8 (Lowe et al., 1993b) were compared with C8 cells transduced with GSE-56 or bcl-2 and with similar ®broblasts from p53-knockout mice, line A4 (Lowe et Figure 2 . DU145 cells were chosen for the demonstration of the eect since they are resistant to many known negative regulatory stimuli, including TGF-b, TNF-a, interferon-g and FAS ligand; these cells are p53-de®cient and do not undergo apoptosis in response to treatment with radiation or DNA-damaging chemotherapeutic drugs (Rokhlin et al., 1997) . The medium from p53-negative cells had no detectable growth inhibitory eects, regardless of whether or not they were irradiated. Conditioned medium from untreated p53 wild type cells did not aect the growth of target cells (blue bars). However, growth inhibition of target DU145 cells was evident only with the medium collected from p53 wild type cells after p53 activation in all three cell systems (red bars, see upper row in Figure 2 ). Growth inhibition was evident in all target cell types tested, although the scale of the eect varied among dierent cells (Figure 2f ). The strength of the growth inhibitory eect correlated with the concentration of conditioned media and could be enriched by ultra®ltration through Amicon ®lters with the cuto of 10 kd (Figure 2f ). We then assessed whether the growth-suppressive eect of the medium collected from the cells after gamma irradiation may stem from the toxicity associated with p53-induced apoptosis. We found that Figure 2 Growth inhibition of target cells by conditioned media and urine depends on p53 activation. Bar diagrams (upper panels) show cell growth rate estimated as percent of [ 3 H]thymidine incorporation by prostate cancer DU145 cells, growing in the presence of conditioned medium from untreated (blue bars, considered as 100%) and gamma-irradiated (red bars) cells. Cells used as sources of conditioned media: (a) Mouse embryo ®broblasts (MEF) transformed with E1a+ras, p53-de®cient (7/7) or p53 wild type (wt), transduced with either bcl-2 (bcl-2) or anti-p53 GSE (GSE). (b) Balb 3T3 cells, line ConA (wt) and their derivatives expressing antip53 GSE (GSE). (c) Human skin ®broblasts MDAH041 (7/7) and TR9-7 (wt). The pink bar corresponds to the medium collected from TR9-7 after tetracycline deprivation. Results of Western immunoblotting with MEF and human ®broblasts, demonstrating p53 induction after gamma irradiation, and X-gal staining of ConA cells (marked Balb 3T3) are shown below. Bottom panel illustrates the growth suppressive eect of conditioned media from short-term cultures of irradiated p53-null (p537/7) and p53-wild type (wt) splenocytes (d) collected at the dierent time points indicated and urine (e) from p53-null and p53-wild type mice before (control) and after gamma irradiation (gamma). Immunoperoxidase staining of irradiated p53-wild type and p53-null splenocytes for p53 is shown in the left bottom corner. In the representative experiment shown, urine samples from six p53-wild type (red crosses) and six p53-null mice (blue dots) harvested before and after irradiation were tested individually. (f) Comparison of growth suppressive eect of dierent dilutions of conditioned medium from gamma irradiated ConA cells on dierent indicated target cells. The conditioned serum-free medium was concentrated (eightfold) by ultra®ltration through Amicon ®lter with cuto 10 kd within the time of the experiment, radiation did not induce apoptosis in human ®broblasts or ConA cells used as a source of conditioned media, as judged by a DNA fragmentation assay (data not shown). Moreover, bcl-2 overexpression did not prevent C8 cells from secreting growth inhibitory factors into the medium, although it blocked apoptosis associated with p53 activation in C8 cells (Nikiforov et al., 1997) (Figure 2 ).
p53-dependent secretion of growth inhibitors ex vivo and in vivo
We also assessed whether p53-dependent secretion of growth inhibitors occurred in primary cell cultures and in vivo in the organism in response to gamma irradiation. Spleen and thymus were chosen for these experiments since they both respond to gamma irradiation by activation of massive p53-dependent apoptosis but dier dramatically in the content of p53-responsive genes (Table 1) . We prepared short-term cultures of splenocytes and thymocytes from untreated and gamma-irradiated p53-wild type and p53-null mice and tested the growth inhibitory eect of conditioned medium at dierent times after treatment. Similarly, urine samples from wild type and p53-knockout C57BL mice were analysed before and 7 h after 10 Gy of gamma radiation. The results of representative experiments summarized in Figure 2 demonstrate the growth-suppressive eect detected both ex vivo in conditioned medium from splenocytes and in vivo in urine of irradiated animals. In both cases, the eect was p53-dependent. Conditioned medium from shortterm cultures of irradiated thymocytes did not display any detectable growth suppressive activity (data not shown); consistently, no genes that encode secreted proteins were identi®ed from thymus (see Table 1 ).
Remarkably, the growth suppressive eects of conditioned medium and urine were more pronounced when tested in the prostate tumor cell line than in nonmalignant cells, including mouse and human diploid ®broblasts and mouse mammary gland epithelial cells NMuMG (Figure 2f ).
p53-dependent bystander eect can potentiate the ecacy of anti-cancer drugs
The p53-dependent secretion of growth inhibitors raises the possibillity that p53 activation in a particular cell population may induce`export' of anti-proliferative stimuli, aecting growth of their neighbors. This means that the anti-tumor eect of chemo-and radiation therapy may be augmented by the bystander eect of p53 activation that results from damage to normal p53-wild type tissues caused by the chemo-and radiation therapy. To test this putative indirect action of chemotherapy, we carried out a series of experiments comparing the impact of the p53 status of nonmalignant ®broblasts on the survival of co-cultivated transformed cells. To distinguish between the direct and indirect eects of chemotherapeutic drug treatment on tumor cells, we used the multidrug-resistant tumor cell line KB8-5-11, which is resistant to the numerous drugs, including adriamycin, due to overexpression of P-glycoprotein (P-gp) (Roninson et al., 1986) . KB8-5-11 cells were plated on sparse monolayers of either p53-de®cient (MDAH041) or p53 wild type (TR9-7 cells) human ®broblasts (1000 KB8-5-11 cells per plate). Such an experimental design imitated tumor growth on p53-de®cient or p53-wild type stroma. Once ®broblasts formed a complete monolayer and KB8-5-11 cells formed small colonies, adriamycin was added. Figure 3 shows the results of this experiment 5 days after 50 ng/ml of the drug was added. This drug concentration led to complete growth arrest, but not apoptosis, in both strains of human ®broblasts (data not shown). Growth of KB8-5-11 cells plated either alone or on the layer of p53-de®cient ®broblasts was also not aected. However, most KB8-5-11 colonies growing on wild type p53 ®broblasts degraded, displaying morphological characteristics of apoptosis. Similar experiments were performed with the colonies of spontaneously transformed Balb 3T3 cells cocultivated with MDAH041 or TR9-7 cells. In these experiments, the induction of p53 expression in TR9-7 cells was achieved by tetracycline deprivation. As in the previous case, the growth of colonies of transformed cells was signi®cantly reduced on the TR9-7 background (data not shown). We concluded that activation of p53 in normal cells could lead to growth inhibition of co-cultivated tumor cells apparently through bystander eect caused by the release of growth inhibitors. This suggests that the anti-cancer eect of chemotherapeutic drugs can be facilitated by druginduced p53 activation in normal tissues.
Discussion
The p53-dependent secretion of growth inhibitors with potential anticancer activity detected both in conditioned medium and in urine indicates a novel growth regulatory function of p53: stress-dependent cellular export of growth inhibitory stimuli. This function possibly determines the`bystander eect' associated with p53 gene therapy (Qazilbash et al., 1997) . Remarkably, the observed growth suppression eect of p53-dependent secreted factors does not depend on the origin (mouse or human) and p53 status of the target cells: DU145 and PC3 cells are p53-de®cient, while the rest of the target cells tested have wild type p53.
What is the nature of p53-dependent secreted growth inhibitors? Analysis of the list of p53 regulated genes identi®ed in the present work and known genes from previous studies indicates that the growth suppressive eect is likely to be a result of activity of a combination of factors. Some of the factors identi®ed in the present work as p53 responders have profound anticancer activity and are already used as supplements to chemotherapeutic treatments. These include members of the TGF-b family as well as numerous serine protease inhibitors and their chemical functional analogs, which are emerging as potential tools to treat cancer (DeClerck and Imren, 1994) . The list of secreted proteins induced by p53 in dierent cell types is obviously incomplete, since we analysed only a few cell types using a limited number of arrayed cDNA probes.
The p53-dependent modulation of gene expression in gamma-irradiated ®broblasts (Table 2) clearly re¯ects morphological and physiological alterations in irradiated tissues associated with a growth attenuation of tumors transplanted in gamma-irradiated organs known as tumor bed eect (O'Brien et al., 1969) . Thus, induction of various collagen species and suppression of collagen-degrading proteinases (stromelysin-1, interstitial collagenase and cathepsin K) correlates with deposition of collagen by connective tissue in coarse bundles following irradiation. Deep p53-dependent suppression of the HAS2 and COX2 genes, which determine production of the potent angiogenic factors hyaluronan and prostaglandin E (Rooney et al., 1995; Gullino, 1995) , along with the previously found activation of thrombospondins 1 and 2 (Dameron et al., 1994) , correlates with the suppression of angiogenesis in irradiated tissues (O'Brien et al., 1969) . These observations allow us to predict that tumor bed eect is a p53-dependent phenomenon.
Morphological and physiological alterations of normal tissues associated with aging may well be another phenomenon related to the newly determined function of p53. Senescent cells that accumulate in tissues over time (Dimri et al., 1995) are known to maintain very high levels of p53-dependent transcription (Atadja et al., 1995) . p53 dependent secretion of growth inhibitors by senescent cells, accumulating in aging tissue, may aect proliferating cells and lead to a gradual decrease in overall proliferative capacity of tissues associated with age and slower tumor growth of solid tumors in old patient. Identi®cation of p53-dependent growth inhibitors will allow this hypothesis to be tested directly.
Materials and methods
Cell lines
p53-negative Li ± Fraumeni ®broblasts (line MDAH041), their derivative expressing wild type p53 under the control of a tetracycline-regulated promoter (line TR9-7) and Balb/ c 3T3 cells 12-1 (Harvey and Levine, 1991) with wild type p53 expressing lacZ under control of p53-dependent promoter (line ConA) were described earlier (Agarwal et al., 1995; Komarova et al., 1997) and were kindly provided by George Stark. Mouse embryo ®broblasts transformed with E1a+ras from p53-wild type (line C8) and p53-null (line A4) ®broblasts were kindly provided by Scott Lowe (Lowe et al., 1993b) . The derivatives of ConA and C8 cells overexpressing bcl-2 or GSE-56 were obtained by retrovirus transduction of the above cDNAs (Nikiforov et al., 1997) . Mouse breast epithelia cell line NMuMG and normal diploid skin ®broblasts were obtained from ATCC. All cell lines were cultivated in DMEM with 10% fetal calf serum. TR9-7 cells were maintained continuously in the presence of 1 mg/ml of tetracycline; to induce p53 expression, cells were incubated without tetracycline for 24 h. Prostate tumor cells PC3, DU145 and LNCAP were previously described (Rokhlin et al., 1997) . Short-term cultures of splenocytes and thymocytes (2 ± 3610 9 cells6ml 71 ), were prepared from freshly isolated and gently desegregated mouse spleens and thymus glands in RPMI media supplemented with 10% fetal calf serum. Animals p53-knockout (Jacks et al., 1994) and control mice (both C57BL/6J) were purchased from Jackson Labs.
Gamma-irradiation
Mice and cell cultures were irradiated (10 Gy) from a GL Shepherd and Associates Model 143-68 Cs 137 source at a dose rate of 4 Gy per min.
cDNA array hybridization
Dierential hybridization analysis was done with CLON-TECH cDNA arrays (Atlas) and with cDNA microarrays provided by QBI Enterprises Ltd. Atlas array consists of 588 selected cDNAs on nylon membrane. QBI arrays were prepared according to previously described technology p53-dependent secretion of growth inhibitors EA Komarova et al (Schena et al., 1995) by Synteni and contain approximately 20 000 cDNAs. Poly(A) + RNA was puri®ed according to standard protocols from dierent mouse tissues and human cell lines. cDNA probe preparation and hybridization was done according to published protocols and manufacturer's recommendations.
Growth inhibition assay
Cell proliferation rate was estimated using [ 3 H]thymidine incorporation as previously described (Rokhlin et al., 1997) . The experiments were repeated three times using four parallel wells for each tested sample. Conditioned media from gamma-irradiated and control cells and urine from irradiated and control mice were colllected 8 h after irradiation, diluted at dierent proportions with fresh media (5 ± 50% for conditioned media and 0.1 ± 1% for urine) and loaded on target cells for 48 h. [ 3 H]thymidine was added for the last 16 h of incubation.
Northern blot hybridization, semi-quantitative RT ± PCR, immunohistochemical detection of p53, Western blot analysis of p53 expression and in situ beta-galactosidase assays
The assays were performed according to standard and previously described protocols.
Sequence analysis DNA and mRNA sequences were retrieved from GEN-BANK Database and searched for p53 binding sites within the range of +2 kb relative to the transcription start point. 1 ± 2 additonal mismatches and 1 ± 7 bp gaps between halfsites were allowed. Weakened consensus RVNCHWG-YYBN 1 ± 8 RVCWHGYYB was used to allow for naturally occurring mutations in known p53 binding sites. Resulting sequences were accepted if they had no more than 3 ± 4 mismatches in total from the previously de®ned consensus (El-Deiry et al., 1992) RRRCWWGYYYN 0 ± 13 RRRCW-WGYYY and no more than one mismatch was allowed inside CWWG core sequences per half-site dimer.
